AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 292: F175-F184, 2007. First published June 20, 2006; doi:10.1152/ajprenal.00050.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/F175    most recent
00050.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fellner, S. K.
Right arrow Articles by Arendshorst, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fellner, S. K.
Right arrow Articles by Arendshorst, W.

Endothelin-A and -B receptors, superoxide, and Ca2+ signaling in afferent arterioles

Susan K. Fellner and William Arendshorst

Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Submitted 13 February 2006 ; accepted in final form 14 June 2006

It is unknown if endothelin-A and -B receptors (ETAR and ETBR) activate the production of superoxide via NAD(P)H oxidase and subsequently stimulate the formation of cyclic adenine diphosphate ribose (cADPR) in afferent arterioles. Vessels were isolated from rat kidney and loaded with fura 2. Endothelin-1 (ET-1) rapidly increased cytosolic Ca2+ concentration ([Ca2+]i) by 303 nM. The superoxide dismutase mimetic tempol, the NAD(P)H oxidase inhibitor apocynin, and nicotinamide, an inhibitor of ADPR cyclase, diminished the response by ~60%. The ETBR agonist sarafotoxin 6c (S6c) increased peak [Ca2+]i by 117 nM. Subsequent addition of ET-1 in the continued presence of S6c caused an additional [Ca2+]i peak of 225 nM. Neither nicotinamide or 8-bromo- (8-Br) cADPR nor apocynin decreased the [Ca2+]i response to S6c, but inhibited the subsequent [Ca2+]i response to ET-1. The ETBR blockers BQ-788 and A-192621 prevented the S6c [Ca2+]i peak and reduced the ET-1 response by more than one-half, suggesting an ETBR/ETAR interaction. In contrast, the ETAR blocker BQ-123 had no effect on the S6c [Ca2+]i peak and obliterated the subsequent ET-1 response. ET-1 immediately stimulated superoxide formation (measured with TEMPO-9-AC, 68 arbitrary units) that was inhibited 95% by apocynin or diphenyl iodonium. S6c or IRL-1620 increased superoxide by 8% of that caused by subsequent ET-1 addition. We conclude that ETAR activation of afferent arterioles increases the formation of superoxide that accounts for ~60% of subsequent Ca2+ signaling. ETBR activation appears to result in only minor increases in superoxide production. Nicotinamide and 8-Br-cADPR results suggest that ET-1 (and primarily ETAR) causes the activation of vascular smooth muscle cell-ADPR cyclase.

renal microcirculation; TEMPO-9-AC; ryanodine receptor; cyclic adenine diphosphate ribose; reduced nicotinamide adenine dinucleotide phosphate oxidase; heterodimerization



Address for reprint requests and other correspondence: S. K. Fellner, Dept. of Cell and Molecular Physiology, Univ. of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599–7545 (e-mail: sfellner{at}med.unc.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. L. Jernigan, B. R. Walker, and T. C. Resta
Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L515 - L529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. L. Thai and W. J. Arendshorst
ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F360 - F368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, C. L. Whitten, and W. J. Arendshorst
Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F719 - F728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. K. Fellner and W. J. Arendshorst
Angiotensin II-stimulated Ca2+ entry mechanisms in afferent arterioles: role of transient receptor potential canonical channels and reverse Na+/Ca2+ exchange
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F212 - F219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. L. Thai, S. K. Fellner, and W. J. Arendshorst
ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1107 - F1114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. K. Fellner and W. J. Arendshorst
Voltage-gated Ca2+ entry and ryanodine receptor Ca2+-induced Ca2+ release in preglomerular arterioles
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1568 - F1572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Just, A. J. M. Olson, C. L. Whitten, and W. J. Arendshorst
Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H83 - H92.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.